Clare Williams
Family Medicine · Murphysboro, ILNPI 1932146271
Payments from drug & device makers
Across 1,045 payments — averaging $15.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- AstraZeneca$1K
- Pfizer$1K
- GSK$1K
- Amgen$1K
- Lilly USA, LLC$988
- plus $8K from 51 others
What the payments were for
- Food & beverage$16,21899%
- Education$911%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,310 in reported general payments places this provider in the 95th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 138 | $149,710 |
| JardianceEmpagliflozin | 134 | $126,461 |
| EliquisApixaban | 149 | $107,371 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 79 | $66,183 |
| JanuviaSitagliptin Phosphate | 64 | $59,286 |
| MounjaroTirzepatide | 49 | $51,787 |
| FarxigaDapagliflozin Propanediol | 42 | $45,044 |
| OzempicSemaglutide | 29 | $41,169 |
| XareltoRivaroxaban | 50 | $39,790 |
| VraylarCariprazine Hcl | 19 | $35,966 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 781 | $29,646 |
| SymbicortBudesonide/Formoterol Fumarate | 83 | $20,877 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 34 | $19,281 |
| Spiriva HandihalerTiotropium Bromide | 30 | $18,699 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 30 | $17,610 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $988 | $201,498187 claims |
| Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat | $416 | $144,312158 claims |
| PfizerEliquis, Abrysvo | $1,291 | $114,616172 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Incruse Ellipta, Breo Ellipta | $1,268 | $104,439170 claims |
| AstraZenecaFarxiga, Symbicort, Breztri Aerosphere, Bevespi Aerosphere | $1,472 | $99,982190 claims |
| MerckJanuvia, Dulera | $552 | $62,81575 claims |
| Novo NordiskOzempic | $639 | $41,16929 claims |
| Johnson & JohnsonXarelto | $493 | $39,79050 claims |
| AbbVieVraylar | $1,599 | $35,96619 claims |
| Astellas Pharma US IncMyrbetriq | $90 | $14,16315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Murphysboro
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
- Mark ChristensenNew Lenox$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.